Lifestyle Factors clinical trials

Explore recruiting lifestyle factors clinical trials.

Recruiting lifestyle factors studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lifestyle Factors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

CIRAANO: Multimodal exploration (including radiopharmaceuticals Amyvid® and Tauvid®) of theater actors, memory athletes, and patients with various memory pathologies: evaluation of mnesic strategies and their cerebral substrates, and contribution to the treatment of memory pathologies.

France

Phase II and Phase III (Integrated) EU CTIS Study details

A low-intervention randomised, double-blind, placebo-controlled pilot trial evaluating the feasibility, tolerability and adherence of alternate-day oral Duroferon (ferrous sulphate) in adolescent girls with iron deficiency, and the diagnostic performance of the IRON-5 screening tool (IRONGIRLS-PILOT).

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

A Phase III b randomized open-label trial on metformin for cancer prevention in adolescents and adults with Li-Fraumeni syndrome (LFS)

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Short-term changes in cardiovascular risk determinants after temporarily stopping gender-affirming hormone therapy in older transgender women - a pilot study

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Effect of Mediterranean diet combined with intermittent fasting on liver fibrosis compared to naltrexone/bupropion (Mysimba) in people with cardiometabolic risk factors

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Impact of the presence of the corpus luteum on pregnancies obtained through frozen embryo transfer(FET): a prospective randomizedcontrolled study

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Lifestyle Factors trials by city

Lifestyle Factors in Toronto Lifestyle Factors in Vancouver Lifestyle Factors in Montreal Lifestyle Factors in Calgary Lifestyle Factors in Edmonton Lifestyle Factors in Ottawa Lifestyle Factors in Winnipeg Lifestyle Factors in Quebec City Lifestyle Factors in Hamilton Lifestyle Factors in Kitchener Lifestyle Factors in London Lifestyle Factors in Halifax Lifestyle Factors in New York Lifestyle Factors in Los Angeles Lifestyle Factors in Chicago Lifestyle Factors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease